AXIM Biotechnologies Competitors and Similar CompaniesClear all
Versea's competitors and similar companies include Kaya Holdings and Zynerba.
 Versea Versea Holdings is a pharmaceutical company focused on the development of molecules for the treatment of inflammatory and other debilitating diseases. |  Kaya Holdings Kaya Holdings owns and operates brands that produce, distribute and sell premium cannabis products, including flower, concentrates, and cannabis-infused baked goods and candies. |  Zynerba Zynerba Pharmaceuticals is a company developing transdermally-delivered cannabinoid therapeutics for patients affected by rare and near-rare neuropsychiatric conditions. | |
Founding Date | Founding Date 2018 | Founding Date 1993 | Founding Date 2014 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Tampa, US HQ Belfast, GB Tampa, US | Locations Fort Lauderdale, US HQ Kallithea, GR Tzur Yitzhak, IL | Locations Devon, US HQ |
Employees | Employees 393% decrease | Employees 620% increase | Employees 2511% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1 m | Valuation ($) 70.1 m |
Financial | |||
Net income | Net income N/A | Net income ($2.2m) (FY, 2024) | Net income ($35m) (FY, 2022) |
For sources of this data, please see the company profile
View Company Profiles
Kaya Holdings
HQ
Fort Lauderdale, US
Employees
6↑ 20% increase
Kaya Holdings owns and operates brands that produce, distribute and sell premium cannabis products, including flower, concentrates, and cannabis-infused baked goods and candies.
View companyZynerba
HQ
Devon, US
Employees
25↓ 11% decrease
Zynerba Pharmaceuticals is a company developing transdermally-delivered cannabinoid therapeutics for patients affected by rare and near-rare neuropsychiatric conditions.
View company